VEREECK, Lode

Email Alert RSS Feed

Profile

Full Name
VEREECK, Lode
Email
lode.vereeck@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Refined By:
Date Issued:  [2010 TO 2019]

Results 21-40 of 48 (Search time: 0.023 seconds).

show all
Issue DateTitleContributor(s)TypeCat.
212015Litigation decisionBIELEN, Samantha; MARNEFFE, Wim; VEREECK, LodeBook SectionB2
222015A Review of Comparative Vehicle Cost AnalysisROOSEN, Jorg; MARNEFFE, Wim; VEREECK, LodeJournal ContributionA1
232015Does debt predict growth? An empirical analysis of the relationship between total debt and economic outputVANLAER, Willem; MARNEFFE, Wim; VEREECK, Lode; VAN OVERTVELDT, JohanJournal ContributionA1
242015Invloed van het Belgische vergoedingssysteem voor medische ongevallen op het gedrag van artsenVANDERSTEEGEN, Tom; MARNEFFE, Wim; LIERMAN, Steven; DE GENDT, Tom; CLEEMPUT, Irina; VANDIJCK, Dominique; VEREECK, LodeJournal ContributionA1
252014Does reducing administrative burdens lead to economic development?: An empirical analysis for the EU.POEL, Kevin; MARNEFFE, Wim; BIELEN, Samantha; VAN AARLE, Bas; VEREECK, LodeConference MaterialC2
262014Administrative Simplification and Economic Growth: A Cross Country Empirical StudyPOEL, Kevin; MARNEFFE, Wim; BIELEN, Samantha; VAN AARLE, Bas; VEREECK, LodeJournal ContributionA2
272014A cross-country analysis of the impact of regulatory quality on commercial case disposition time.MARNEFFE, Wim; BIELEN, Samantha; VEREECK, LodeConference MaterialC2
282014Administrative burdens and economic growth in EuropeMARNEFFE, Wim; POEL, Kevin; BIELEN, Samantha; VEREECK, LodeConference MaterialC2
292014The impact of no-fault compensation on health care expenditures: An empirical study of OECD countriesVANDERSTEEGEN, Tom; MARNEFFE, Wim; CLEEMPUT, Irina; VEREECK, LodeConference MaterialC2
302014Cost-effectiveness of gemcitabine versus PEGylated liposomal doxorubicin for recurrent or progressive ovarian cancer: comparing chemotherapy with nanotherapyBOSETTI, Rita; Ferrandina, Gabriella; MARNEFFE, Wim; Scambia, Giovanni; VEREECK, LodeJournal ContributionA1
312014A cross-country analysis of the impact of regulatory quality on commercial case disposition timeBIELEN, Samantha; MARNEFFE, Wim; VEREECK, LodeJournal ContributionA1
322014Physician specialists’ perceptions of the medical malpractice reform in BelgiumVANDERSTEEGEN, Tom; MARNEFFE, Wim; DE GENDT, Tom; CLEEMPUT, Irina; VANDIJCK, Dominique; VEREECK, LodeConference MaterialC2
332013Assessing the need of quality-adjusted cost-effectiveness studies of nanotechnological cancer therapiesBOSETTI, Rita; MARNEFFE, Wim; VEREECK, LodeConference MaterialC2
342013Handboek Openbare financiënMARNEFFE, Wim; VEREECK, Lode; Matthijs, Herman; Naert, FrankBookB1
352013De impact van wetgevingskwaliteit op de gerechtelijke achterstandBIELEN, Samantha; MARNEFFE, Wim; OOMS, Anne; VEREECK, LodeJournal ContributionA1
362013Assessing the need for quality-adjusted cost–effectiveness studies of nanotechnological cancer therapiesBOSETTI, Rita; MARNEFFE, Wim; VEREECK, LodeJournal ContributionA1
372013Regulatory delay and growth: a cross country analysisMARNEFFE, Wim; VAN AARLE, Bas; VEREECK, LodeJournal ContributionA1
382012De waarde van snellere vergunningsprocedures voor Vlaamse ondernemersMARNEFFE, Wim; VEREECK, LodeBook SectionB2
392012The impact of effective patents on future innovations in nanomedicineBOSETTI, Rita; VEREECK, LodeJournal ContributionA2
402012Valuing the reduced risk of mortality and injuries: findings from a contingent valuation study in FlandersDE BRABANDER, Bram; MARNEFFE, Wim; VEREECK, LodeJournal ContributionA1
show all